In addition, similarities to prior EAE studies [5,9] using an alternative treatment delivery, which also showed that RGC survival was increased without a significant reduction in optic nerve inflammation, is more suggestive of disease-selective effects of resveratrol and other SIRT1-based therapies promoting neuroprotection without anti-inflammatory effects in optic neuritis. This evidence concerns the gene SIRT1 and optic neuritis.